The Discounted Cash Flow (DCF) valuation of Arcus Biosciences Inc (RCUS) is (474.26) USD. With the latest stock price at 11.75 USD, the upside of Arcus Biosciences Inc based on DCF is -4136.2%.
Based on the latest price of 11.75 USD and our DCF valuation, Arcus Biosciences Inc (RCUS) is a sell. selling Arcus stocks now will result in a potential gain of 4136.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.3% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,022.62) - (312.43) | (474.26) |
| Upside | -8803.2% - -2759.0% | -4136.2% |